PDB36 Reduced Rates of Hypoglycemia Lead to Cost Savings for Type 2 Diabetic Patients Treated with Saxagliptin Versus Sulphonlyurea in Actual Clinical Practice
Abstract
Authors
D.L. Becker S.W. Thayer B. Zhang M. Skornicki J.P. Graham K.F. Bell